Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma
Jeffrey W. Martin, Susan Chilton-MacNeill, Madhuri Koti, Andre J. Van Wijnen, Jeremy A. Squire, Maria Zielenska
Dive into the research topics of 'Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma'. Together they form a unique fingerprint.